Skip To Main Content
Nadine McGrath on Muck Rack

Nadine McGrath

Verified
(She/Her)
Brisbane
As seen in: Stockhead, MSN Australia, News.com.au, Frontline Gastroenterology, The Daily Telegraph, The Herald Sun, The Australian Business Review, The Australian, The Courier-Mail, The Money Puzzle, EIN News and
Journalist specialising in finance & economy working @stockheadAU. Views expressed here are my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nadine

Contact Nadine, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Scott Power: ASX healthcare lifts ahead of FY26 results from sector heavyweights Original

|
By Nadine McGrath Verified
| Stockhead Verified
The ASX healthcare sector is up 2.73% this week, powering ahead of the broader market which was down 1.45% Some of the sector’s biggest names due to report including CSL, Cochlear and ProMedicus Morgans reduces 12-month price target of ResMed from $39.50 from $40.97 following Q4 FY26 results Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his take on the ASX healthcare sector for the week.
Open in Who Shared View Duplicates (3) Issue with article?

Powerhouse of the cell: ASX biotechs target the next frontier in healthy ageing

|
By Nadine McGrath Verified
| MSN Australia Verified
Nadine McGrath Known as the ‘powerhouse of the cell', mitochondria are becoming a focus of research into ageing, health and disease ASX healthcare companies are focusing on supplements supporting cell function and therapies targeting dysfunction linked to disease EZZ Life Science co-funded research proposing that three compounds associated with healthy ageing may act more effectively in combination to prevent mitochondrial decline For decades, the pursuit of better health and ageing well has...
Open in Who Shared Issue with article?

Powerhouse of the cell: ASX biotechs target the next frontier in healthy ageing

|
By Nadine McGrath Verified
| Stockhead Verified
Known as the ‘powerhouse of the cell’, mitochondria are becoming a focus of research into ageing, health and disease ASX healthcare companies are focusing on supplements supporting cell function and therapies targeting dysfunction linked to disease EZZ Life Science co-funded research proposing that three compounds associated with healthy ageing may act more effectively in combination to prevent mitochondrial decline For decades, the pursuit of better health and ageing well has focused on...
Open in Who Shared Issue with article?
See all 1,875 licensed articles (4,023 Total)